Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Gastrointestinal Stromal Tumors

fluorodeoxyglucose f18 has been researched along with Gastrointestinal Stromal Tumors in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	36 (37.89)	29.6817
2010's	50 (52.63)	24.3611
2020's	9 (9.47)	2.80

Authors

Authors	Studies
Cui, G; Du, W; Li, S; Wang, K	1
Cheng, C; Jiang, H; Zhang, L; Zhang, Z; Zuo, C	1
Hayano, K; Matsubara, H; Mori, M; Narushima, K; Ohira, G; Okazumi, S; Shuto, K; Yanagawa, N	1
Huang, Z; Jiang, Y; Lou, C; Lu, Q	1
Albano, D; Bertagna, F; Giubbini, R; Mattia, B	1
Han, JK; Kim, SH; Yoo, J	1
Khan, KS; Mahmud, S; Mathias, N; Reed-Embleton, H	1
Bender, L; Gantzer, J; Imperiale, A; Kurtz, JE; Somme, F	1
Bruland, ØS; Hole, KH; Julsrud, L; Mo, T; Reitan, E; Revheim, ME; Seierstad, T	1
Boonstra, PA; Desar, I; Farag, S; Gelderblom, H; Geus-Oei, LF; Grunhagen, D; Reyners, AKL; Steeghs, N; van Coevorden, F; van der Graaf, WT	1
Kim, SJ; Lee, SW	1
Alabed, YZ	1
Aoyagi, T; Hayano, K; Kurata, Y; Matsubara, H; Narushima, K; Ohira, G	1
Cao, N; Ge, L; Lu, C; Pan, B; Wei, K; Yang, H	1
Hornick, JL; Jagannathan, JP; Ramaiya, NH; Tirumani, SH	1
Bjerkehagen, B; Bruland, OS; Hole, KH; Julsrud, L; Reitan, E; Revheim, ME; Seierstad, T	1
Dunet, V; Koehli, M; Meuli, R; Montemurro, M; Prior, JO; Schmidt, S	1
Chan, Q; Chu, YC; Gong, NJ; Guo, H; Huang, B; Wong, CS	1
Babicky, ML; French, RP; Hoh, CK; Jaquish, DV; Leonard, SY; Lowy, AM; Mose, ES; Peterson, M; Schwab, R; Sicklick, JK; Tang, CM	1
Chong, A; Ha, JM; Hong, R; Lee, HJ; Park, SG	1
Bae, KS; Choi, BH; Jeong, CY; Kim, HO; Kim, JE; Lee, JS	1
Barquin, E; Collins, B; Gardner, K; Judson, I; Jürgensmeier, JM; Leahy, M; Marotti, M; Scurr, M; Young, H	1
Fujikuni, N; Misumi, T; Ohdan, H; Suzuki, T; Tanabe, K; Tokumoto, N	1
Dimitrakopoulou-Strauss, A; Hohenberger, P; Niedermoser, S; Ronellenfitsch, U; Wängler, B	1
Hirokawa, T; Matsuo, Y; Morimoto, M; Sato, M; Sato, T; Shamoto, T; Shibata, T; Takahashi, H; Takeyama, H; Tsuboi, K	1
Antonescu, C; Bains, MS; Gollub, MJ; Levine, MS; Shia, J; Winant, AJ	1
Decker, J; Dunzinger, A; Kieberger, A; Pichler, R; Weis, S	1
Chacón, M; Eleta, M; Espindola, AR; Méndez, G; Pupareli, C; Roca, E; Rojo, S	1
Cho, A; Cho, MH; Kim, H; Kim, WK; Park, CK; Park, M	1
Asady, H; Fard-Esfahani, A; Hassanzadeh-Rad, A; Hosseini, M; Katal, S; Moghadas Jafari, A; Yousefifard, M	1
Higashi, T; Mikami, Y; Minami, S; Miyake, KK; Nakamoto, Y; Saga, T; Tadamura, E; Tanaka, S; Togashi, K	1
Amantea, MA; Friberg, LE; Karlsson, MO; Schindler, E	1
Hashimoto, J; Hirabayashi, K; Ichikawa, T; Imai, Y; Mori, N; Yamada, M; Yamashita, T	1
Nguyen, BD; Sugrue, G	1
Baghel, NS; Dutt, A; Nair, N; Shinto, A	1
Almusa, O; Daly, B; Shreve, P	1
de Geus-Oei, LF; de Rooy, JW; Oyen, WJ; van de Luijtgaarden, AC; van der Graaf, WT	1
Asopa, R; Basu, S; Mohandas, KM; Peshwe, H	1
Asopa, R; Basu, S; Mohandas, KM; Peshwe, H; Vyawahare, M	1
Eslamy, HK; Quon, A	1
Benhattar, J; Delaloye, AB; Elsig, V; Guillou, L; Leyvraz, S; Luthi, F; Michielin, O; Montemurro, M; Orcurto, MV; Prior, JO; Stupp, R	1
Barzilai, M; Domachevsky, L; Peled, N	1
Dietrich, C; Hartung, E; Ignee, A	1
Harada, M; Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K	1
Benjamin, R; Fitzgerald, TJ; Scheutze, S; Shankar, LK; Van den Abbeele, A; Yap, J	1
Juengling, FD; Kohl, S; Krause, TM; Siebenrock, KA; Stauffer, E; Wissmeyer, M	1
Arisaka, Y; Fujii, H; Fukuda, H; Hara, T; Hayashi, T; Kaneta, T; Kitajima, K; Kubota, K; Murakami, K; Nakamoto, Y; Oriuchi, N; Takahashi, S; Tateishi, U; Terauchi, T	1
Antonescu, CR; Baum, CM; Bello, CL; Chen, MH; Cohen, DP; Corless, CL; Demetri, GD; Fletcher, CD; Fletcher, JA; George, S; Heinrich, MC; Huang, X; Maki, RG; Morgan, JA; Van den Abbeele, AD	1
Antoch, G; Buck, AK; Herrmann, K; Heusner, TA	1
Gauthier, H	1
Ayala-Ramirez, M; Callender, GG; Chuang, HH; Goodarzi, M; Jimenez, C; Kupferman, ME; Perrier, ND; Rich, TA; Trent, J	1
Basu, S	1
Kochhar, R; Leahy, M; Manoharan, P; Taylor, MB	1
Furutani, K; Harada, M; Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K	1
Cervino, AR; Evangelista, L; Gregianin, M; Sala-Dini, G	1
Antoch, G; Bauer, S; Bockisch, A; Ebeling, P; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Stahl, A	1
Benatsou, B; Bidault, S; Blay, JY; Chami, L; Chebil, M; Cioffi, A; Koscielny, S; Lassau, N; Le Cesne, A; Massard, C	1
Ayuso, JR; Casado, A; Cubedo, R; Del Muro, XG; Fuster, D; Lomeña, F; López-Pousa, A; Martínez-Trufero, J; Maurel, J; Pons, F; Poveda, A	1
Bellan, E; Biasco, G; Boschi, S; Castelli, M; Castellucci, P; Di Battista, M; Fanti, S; Gnocchi, C; Landuzzi, L; Lollini, PL; Nanni, C; Nannini, M; Nicoletti, G; Pantaleo, MA; Quarta, C; Rubello, D	1
Apostolopoulos, DJ; Dimitrakopoulou-Strauss, A; Hohenberger, P; Roumia, S; Strauss, LG	1
Bertagna, F; Biasiotto, G; Bosio, G; Giubbini, R; Orlando, E	1
Iwano, S; Kato, K; Koike, W; Naganawa, S; Ueda, Y; Usami, N; Yokoi, K	1
Anthony, MP; Chan, Q; Chu, KM; Chu, YC; Gong, N; Khong, PL; Lee, HF; Wong, CS	1
Choi, H	2
Hatazawa, J; Isohashi, K; Kato, H; Shimosegawa, E; Tatsumi, M; Watabe, H; Watabe, T; Yanagawa, M	1
Banerjee, P; Kung, AL; Tseng, JC; Wang, Y	1
Blevins, M; de Vries, DJ; Eisenberg, B; Gatsonis, C; Godwin, AK; Huang, M; Melenevsky, Y; Rink, L; Sicks, J; Siegel, BA; Szot-Barnes, A; Van den Abbeele, AD; Yap, JT	1
Butrynski, J; Hornick, JL; Jagannathan, JP; Krajewski, KM; Ramaiya, NH; Shinagare, AB; Zukotynski, KA	1
Dimitrakopoulou-Strauss, A; Hohenberger, P; Koczan, D; Pan, L; Strauss, LG	1
Higashi, K; Miyata, T; Nakano, T; Sasaki, S; Tsukada, T	1
Carrió-Gasset, I; Fuertes-Cabero, S; García-Garzón, JR; Lomeña-Caballero, F; Moragas-Solanes, M; Ponce-López, A; Riera-Gil, E; Soler-Peter, M; Valls-Ferrusola, E	1
Gallowitsch, HJ; Malle, P; Sorschag, M	1
Akhurst, TJ; Antonescu, CR; D'Adamo, DR; Dickson, MA; Keohan, ML; Maki, RG; Okuno, SH; Schwartz, GK	1
Iwata, T; Kashihara, H; Kurita, N; Matsumoto, N; Miyatani, T; Morimoto, S; Sato, H; Shimada, M; Takasu, C; Yoshikawa, K	1
Hornick, JL; Jagannathan, JP; Koch, MR; Krajewski, KM; Ramaiya, NH; Raut, CP; Shinagare, AB	1
Benjamin, RS; Charnsangavej, C; Choi, H; de Castro Faria, S; Johnson, MM; Macapinlac, HA; Podoloff, DA; Tamm, EP	1
Chang, WC; Cheng, CY; Hsu, HH; Shen, DH; Tzao, C; Yu, CP	1
Aihara, R; Asao, T; Endo, K; Kamiyama, Y; Kuwano, H; Mochiki, E; Nakabayashi, T; Oriuchi, N	1
Kendler, D; Moncayo, R; Virgolini, I; Zaknun, JJ; zur Nedden, D	1
Erturk, SM	1
Ashman, LK; Binns, D; Conus, N; Cullinane, C; Dorow, DS; Hicks, RJ; Kansara, M; McArthur, GA; Thomas, DM	1
Dixon, J; Goldstein, D; Haindl, W; Rossleigh, M; Tan, BS; Walker, B	1
Ahlman, H; Bümming, P; Nilsson, B; Nilsson, O; Sörensen, J	1
Schuetze, SM	1
Ando, T; Goto, H; Hirooka, Y; Itoh, A; Maeda, O; Matsuura, T; Miyahara, R; Niwa, Y; Ohashi, A; Ohmiya, N; Yamada, M	1
Camci, C; Kalender, ME; Sevinc, A; Zincirkeser, S	1
Benjamin, RS; Burgess, MA; Charnsangavej, C; Chen, LL; Choi, H; Faria, SC; Macapinlac, HA; Patel, SR; Podoloff, DA	1
Dimitrakopoulou-Strauss, A; Eisenhut, M; Haberkorn, U; Hohenberger, P; Mäcke, HR; Strauss, LG	1
Guillén Ponce, C; Molina Garrido, MJ	1
Badawi, RD; Demetri, GD; Holdsworth, CH; Israel, DA; Kijewski, MF; Manola, JB; Van den Abbeele, AD	1
Banzo, I; Barragan, J; Carril, JM; Jimenez-Bonilla, J; Martinez-Rodriguez, I; Portilla-Quattrociocchi, H; Quirce, R; Sainz-Esteban, A	1
Abhyankar, SA; Nair, N	1
Buchmann, I; Ganten, TM; Haberkorn, U	1
Van den Abbeele, AD	1

Reviews

16 review(s) available for fluorodeoxyglucose f18 and Gastrointestinal Stromal Tumors

Article	Year
Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis. Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:3 Topics: Databases, Bibliographic; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity	2018
F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy. Medicine, 2018, Volume: 97, Issue:16 Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Research Design; Tomography, X-Ray Computed	2018
Resistance to treatment in gastrointestinal stromal tumours: what radiologists should know. Clinical radiology, 2013, Volume: 68, Issue:8 Topics: Antineoplastic Agents; Benzamides; Contrast Media; Disease Progression; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mutation; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Odds Ratio; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome; Young Adult	2016
Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice. Cancer imaging : the official publication of the International Cancer Imaging Society, 2008, Oct-04, Volume: 8 Spec No A Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Sarcoma	2008
FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor. Nuclear medicine communications, 2008, Volume: 29, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidines; Tomography, X-Ray Computed	2008
Considerations for the use of imaging tools for phase II treatment trials in oncology. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Mar-15, Volume: 15, Issue:6 Topics: Clinical Trials, Phase II as Topic; Endpoint Determination; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Neoplasms; Positron-Emission Tomography; Quality Assurance, Health Care; Sarcoma	2009
[Imaging procedures for gastrointestinal stromal tumors]. Der Radiologe, 2009, Volume: 49, Issue:12 Topics: Blood Glucose; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed	2009
[Positron emission tomography and evaluation of response to targeted therapies]. Bulletin du cancer, 2009, Volume: 96, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Hypoxia; Cell Proliferation; Choline; ErbB Receptors; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Lipid Metabolism; Lung Neoplasms; Neoplasms; Neovascularization, Pathologic; Piperazines; Positron-Emission Tomography; Protein Biosynthesis; Protein Kinases; Pyrimidines; Radiopharmaceuticals; Receptors, Androgen; Receptors, Estrogen; TOR Serine-Threonine Kinases	2009
Imaging in gastrointestinal stromal tumours: current status and future directions. Clinical radiology, 2010, Volume: 65, Issue:8 Topics: Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2010
Imaging modalities of gastrointestinal stromal tumors. Journal of surgical oncology, 2011, Volume: 104, Issue:8 Topics: Endosonography; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours. Wiener medizinische Wochenschrift (1946), 2012, Volume: 162, Issue:19-20 Topics: Antineoplastic Agents; Benzamides; Blood Glucose; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Molecular Targeted Therapy; Multimodal Imaging; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Pyrroles; Sensitivity and Specificity; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome	2012
Utility of positron emission tomography in sarcomas. Current opinion in oncology, 2006, Volume: 18, Issue:4 Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Sarcoma	2006
[[18F]-FDG-PET in the diagnostics of gastrointestinal tumors]. Zeitschrift fur Gastroenterologie, 2008, Volume: 46, Issue:4 Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
Response evaluation of gastrointestinal stromal tumors. The oncologist, 2008, Volume: 13 Suppl 2 Topics: Antineoplastic Agents; Benzamides; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008
The lessons of GIST--PET and PET/CT: a new paradigm for imaging. The oncologist, 2008, Volume: 13 Suppl 2 Topics: Benzamides; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Recurrence, Local; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2008

Trials

10 trial(s) available for fluorodeoxyglucose f18 and Gastrointestinal Stromal Tumors

Article	Year
Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-01, Volume: 20, Issue:13 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome	2014
PK-PD modeling of individual lesion FDG-PET response to predict overall survival in patients with sunitinib-treated gastrointestinal stromal tumor. CPT: pharmacometrics & systems pharmacology, 2016, Volume: 5, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Indoles; Models, Biological; Models, Statistical; Nonlinear Dynamics; Positron-Emission Tomography; Pyrroles; Radiopharmaceuticals; Sunitinib; Survival Analysis; Survival Rate; Treatment Outcome; Tumor Burden	2016
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jan-20, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease Progression; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Mutation; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Salvage Therapy; Sunitinib	2009
Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Sep-15, Volume: 15, Issue:18 Topics: Adult; Aged; Benzamides; Cell Proliferation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Sunitinib; Treatment Failure	2009
Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib. Investigational new drugs, 2012, Volume: 30, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Blood Volume; Contrast Media; Female; Fluorodeoxyglucose F18; France; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Molecular Targeted Therapy; Perfusion Imaging; Phospholipids; Piperidines; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Radiopharmaceuticals; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Platelet-Derived Growth Factor; Sulfur Hexafluoride; Thiazoles; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography	2012
Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spain; Treatment Outcome	2011
ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Benzamides; Biological Transport; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Genotype; Glucose Transporter Type 4; Humans; Image Processing, Computer-Assisted; Imatinib Mesylate; Male; Middle Aged; Mutation; Neoadjuvant Therapy; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Time Factors; Treatment Outcome; Young Adult	2012
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:1 Topics: Adenine; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; HSP90 Heat-Shock Proteins; Humans; Male; Middle Aged; Positron-Emission Tomography; Pyridines; Treatment Outcome	2013
CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR. American journal of roentgenology, 2004, Volume: 183, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Multivariate Analysis; Piperazines; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2004
CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR. American journal of roentgenology, 2007, Volume: 189, Issue:6 Topics: Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Pilot Projects; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; United States	2007

Other Studies

69 other study(ies) available for fluorodeoxyglucose f18 and Gastrointestinal Stromal Tumors

Article	Year
Clinical significance of European journal of medical research, 2022, Sep-16, Volume: 27, Issue:1 Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Glucose; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2022
68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in the Detection of Malignant Gastrointestinal Stromal Tumor. Clinical nuclear medicine, 2023, Jan-01, Volume: 48, Issue:1 Topics: Aged; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET. Scientific reports, 2023, 02-08, Volume: 13, Issue:1 Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2023
Primary Hepatic Gastrointestinal Stromal Tumor on 18 F-FDG PET/CT Images. Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8 Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Liver; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
Role of 18F-FDG PET/CT in restaging and follow-up of patients with GIST. Abdominal radiology (New York), 2020, Volume: 45, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity	2020
Multiparametric MRI and European radiology, 2020, Volume: 30, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Multiparametric Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms	2020
Case report: incidental findings of COVID-19 infection on positron emission tomography/computed tomography for staging of a giant gastric gastrointestinal stromal tumor. The Pan African medical journal, 2020, Volume: 35, Issue:Suppl 2 Topics: COVID-19; COVID-19 Testing; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiography; Stomach Neoplasms	2020
18F-FDG PET/CT Monitoring of Tumor Response to Tyrosine Kinase Inhibitors and Alkylating Drugs in an SDH-Deficient GIST. Clinical nuclear medicine, 2021, Oct-01, Volume: 46, Issue:10 Topics: Alkylating Agents; Child; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Mutation; Pharmaceutical Preparations; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Succinate Dehydrogenase; Young Adult	2021
Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors. Acta radiologica (Stockholm, Sweden : 1987), 2022, Volume: 63, Issue:8 Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiopharmaceuticals	2022
Early Evaluation of Response Using Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult	2018
Gastrointestinal Stromal Tumor of the Prostate: Staging and Evaluation of Response to Therapy With 18F-FDG PET/CT. Clinical nuclear medicine, 2018, Volume: 43, Issue:1 Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Treatment Outcome	2018
Fractal analysis of contrast-enhanced CT images for preoperative prediction of malignant potential of gastrointestinal stromal tumor. Abdominal radiology (New York), 2018, Volume: 43, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Fractals; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Tomography, X-Ray Computed	2018
Multimodal functional imaging for early response assessment in GIST patients treated with imatinib. Acta oncologica (Stockholm, Sweden), 2014, Volume: 53, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2014
Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT. Acta radiologica (Stockholm, Sweden : 1987), 2013, Volume: 54, Issue:8 Topics: Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms; Male; Meglumine; Middle Aged; Multimodal Imaging; Observer Variation; Organometallic Compounds; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Treatment Outcome	2013
Increasing the accuracy of volume and ADC delineation for heterogeneous tumor on diffusion-weighted MRI: correlation with PET/CT. International journal of radiation oncology, biology, physics, 2013, Oct-01, Volume: 87, Issue:2 Topics: Algorithms; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Image Processing, Computer-Assisted; Linear Models; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden	2013
Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor. Journal of translational medicine, 2014, Feb-10, Volume: 12 Topics: Aged; Animals; Demography; Disease Progression; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Mice; Mice, SCID; Middle Aged; Positron-Emission Tomography; Ultrasonography; Xenograft Model Antitumor Assays	2014
Inflammatory myofibroblastic tumor mimicking gastric gastrointestinal stromal tumor on 18F-FDG PET/CT. Clinical nuclear medicine, 2014, Volume: 39, Issue:8 Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Muscle Tissue; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed	2014
Imaging findings of primary malignant gastrointestinal stromal tumor of the liver. Japanese journal of radiology, 2014, Volume: 32, Issue:6 Topics: Aged; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Gadolinium DTPA; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Iohexol; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors. Digestive surgery, 2014, Volume: 31, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden	2014
[Importance of PET for surgery of gastrointestinal stromal tumors]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2014, Volume: 85, Issue:6 Topics: Combined Modality Therapy; Energy Metabolism; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Molecular Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tumor Burden	2014
Inflammatory pseudotumor of the liver diagnosed as metastatic liver tumor in a patient with a gastrointestinal stromal tumor of the rectum: report of a case. World journal of surgical oncology, 2014, May-06, Volume: 12 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Inflammation; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed	2014
Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors. AJR. American journal of roentgenology, 2014, Volume: 203, Issue:2 Topics: Adult; Aged; Barium Sulfate; Biopsy; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Leiomyoma; Leiomyosarcoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Unusual loss of FDG uptake in recurrent GIST. Nuklearmedizin. Nuclear medicine, 2014, Aug-06, Volume: 53, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed	2014
Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors. Future oncology (London, England), 2015, Volume: 11, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Image Interpretation, Computer-Assisted; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome	2015
Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors. PloS one, 2015, Volume: 10, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Carrier Proteins; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression; Glucose; Glucose Transporter Type 1; Hexokinase; Humans; Immunohistochemistry; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Grading; Positron-Emission Tomography; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2015
The predictive value of preoperative European radiology, 2016, Volume: 26, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gastrointestinal Tract; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies	2016
Cholangiolocellular Carcinoma of the Liver Exhibiting High F-18 FDG Uptake. The Tokai journal of experimental and clinical medicine, 2016, Jun-20, Volume: 41, Issue:2 Topics: Aged; Cholangiocarcinoma; Diagnosis, Differential; Duodenal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Male; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Gastrointestinal stromal tumour in neurofibromatosis 1: 18F FDG PET/CT imaging. BMJ case reports, 2016, Aug-16, Volume: 2016 Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Jejunal Neoplasms; Middle Aged; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib. Clinical nuclear medicine, 2008, Volume: 33, Issue:7 Topics: Antineoplastic Agents; Benzamides; Biopsy, Fine-Needle; Diagnostic Imaging; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed	2008
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis. Seminars in ultrasound, CT, and MR, 2008, Volume: 29, Issue:4 Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed	2008
Diffuse intense FDG uptake in the bone marrow in gastrointestinal stromal tumor with coexistent polycythemia rubra vera. Clinical nuclear medicine, 2008, Volume: 33, Issue:11 Topics: Bone Marrow; False Positive Reactions; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Multipotent Stem Cells; Polycythemia Vera; Positron-Emission Tomography	2008
PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy. Clinical nuclear medicine, 2008, Volume: 33, Issue:12 Topics: Antineoplastic Agents; Benzamides; Calcinosis; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Middle Aged; Peritoneum; Piperazines; Positron-Emission Tomography; Prostheses and Implants; Pyrimidines; Tomography, X-Ray Computed	2008
Sonography of multifocal Brucella orchitis. Ultraschall in der Medizin (Stuttgart, Germany : 1980), 2008, Volume: 29 Suppl 5 Topics: Adult; Antineoplastic Agents; Benzamides; Brucellosis; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Hemangioma; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Piperazines; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography	2008
The use of contrast-enhanced ultrasound in patients with GIST metastases that are negative in CT and PET. Ultraschall in der Medizin (Stuttgart, Germany : 1980), 2008, Volume: 29 Suppl 5 Topics: Adult; Antineoplastic Agents; Benzamides; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography	2008
A case of von Recklinghausen's disease with coincident malignant peripheral nerve sheath tumor and gastrointestinal stromal tumor. The journal of medical investigation : JMI, 2009, Volume: 56, Issue:1-2 Topics: Bone Neoplasms; Femur; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Nerve Sheath Neoplasms; Osteitis Fibrosa Cystica; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
FDG uptake in giant cell tumor of the tendon sheath in a patient restaged for gastrointestinal stroma tumor (GIST). Clinical nuclear medicine, 2009, Volume: 34, Issue:3 Topics: Aged; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Giant Cell Tumors; Humans; Male; Membranes; Neoplasm Staging; Positron-Emission Tomography; Tendons; Tomography, X-Ray Computed	2009
Clinical significance of performing 18F-FDG PET on patients with gastrointestinal stromal tumors: a summary of a Japanese multicenter study. Annals of nuclear medicine, 2009, Volume: 23, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Japan; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies	2009
Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome. Nature reviews. Endocrinology, 2010, Volume: 6, Issue:2 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carney Complex; Chromogranin A; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Gene Transfer Techniques; Humans; Hypertension; Lymphatic Metastasis; Male; Metanephrine; Mutation; Neck; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Succinate Dehydrogenase; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2010
PET and PET/CT in gastrointestinal stromal tumours: the unanswered questions and the potential newer applications. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:7 Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2010
Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors. The journal of medical investigation : JMI, 2010, Volume: 57, Issue:3-4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; In Vitro Techniques; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed	2010
FDG-PET/CT visualises a case of primary hyperparathyroidism in patient with GIST. Minerva endocrinologica, 2010, Volume: 35, Issue:3 Topics: Adult; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Hyperparathyroidism, Primary; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Nodule	2010
Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection? European journal of radiology, 2011, Volume: 80, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome	2011
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. Journal of experimental & clinical cancer research : CR, 2010, Dec-30, Volume: 29 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Enzyme Inhibitors; Everolimus; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Mice; Mice, Knockout; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiopharmaceuticals; Receptor, Platelet-Derived Growth Factor alpha; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2010
Parametric images via dynamic 18F-fluorodeoxyglucose positron emission tomographic data acquisition in predicting midterm outcome of liver metastases secondary to gastrointestinal stromal tumours. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:7 Topics: Adult; Aged; Cohort Studies; Discriminant Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Image Interpretation, Computer-Assisted; Linear Models; Liver Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Positron-Emission Tomography; Prognosis; Retrospective Studies	2011
Role of F-18-FDG-PET/CT in restaging of patients affected by gastrointestinal stromal tumours (GIST). Nuclear medicine review. Central & Eastern Europe, 2010, Volume: 13, Issue:2 Topics: Benzamides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Pyrimidines; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed	2010
Images of a case of Carney triad by combined F-18 FDG PET/CT. Clinical nuclear medicine, 2011, Volume: 36, Issue:8 Topics: Adolescent; Chondroma; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Lung Neoplasms; Neoplasms, Multiple Primary; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult	2011
Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. European journal of radiology, 2012, Volume: 81, Issue:9 Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed	2012
Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT. Annals of nuclear medicine, 2012, Volume: 26, Issue:3 Topics: Abdominal Neoplasms; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2012
Incongruity of imaging using fluorescent 2-DG conjugates compared to 18F-FDG in preclinical cancer models. Molecular imaging and biology, 2012, Volume: 14, Issue:5 Topics: Animals; Deoxyglucose; Fluorescence; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imaging, Three-Dimensional; Luminescent Measurements; Mice; Mice, Nude; Microscopy, Confocal; Pyrimidines; Radionuclide Imaging; Spectroscopy, Near-Infrared; Xenograft Model Antitumor Assays	2012
Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer imaging : the official publication of the International Cancer Imaging Society, 2012, Apr-27, Volume: 12 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Combined Modality Therapy; Electronic Health Records; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasms, Second Primary; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2012
Correlation of dynamic PET and gene array data in patients with gastrointestinal stromal tumors. TheScientificWorldJournal, 2012, Volume: 2012 Topics: Adult; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Humans; Male; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Protein Array Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic	2012
Xanthogranulomatous gastritis mimicking malignant GIST on F-18 FDG PET. Annals of nuclear medicine, 2012, Volume: 26, Issue:9 Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gastritis; Gastrointestinal Stromal Tumors; Granuloma; Humans; Male; Middle Aged; Positron-Emission Tomography	2012
Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT. Revista espanola de enfermedades digestivas, 2012, Volume: 104, Issue:7 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Monitoring; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2012
Efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors. Surgery today, 2013, Volume: 43, Issue:10 Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Risk; Tomography, X-Ray Computed	2013
Imaging features of primary anorectal gastrointestinal stromal tumors with clinical and pathologic correlation. Cancer imaging : the official publication of the International Cancer Imaging Society, 2013, Feb-08, Volume: 12 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2013
Gastrointestinal stromal tumor (GIST) of the esophagus detected by positron emission tomography/computed tomography. Digestive diseases and sciences, 2005, Volume: 50, Issue:7 Topics: Adult; Antigens, CD34; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Immunohistochemistry; Male; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Radiopharmaceuticals; Staining and Labeling; Tomography, X-Ray Computed	2005
18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World journal of surgery, 2005, Volume: 29, Issue:11 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2005
F-18 FDG PET for assessing tyrosine kinase-related signal transduction inhibition in a GIST c-kit-positive tumor patient by imatinib. Clinical nuclear medicine, 2005, Volume: 30, Issue:11 Topics: Antineoplastic Agents; Benzamides; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Radiopharmaceuticals; Signal Transduction; Treatment Outcome	2005
CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate. AJR. American journal of roentgenology, 2005, Volume: 185, Issue:5 Topics: Antineoplastic Agents; Benzamides; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2005
An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer research, 2005, Nov-01, Volume: 65, Issue:21 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Mice; Mice, Inbred DBA; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Xenograft Model Antitumor Assays	2005
Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study. Oncology, 2005, Volume: 69, Issue:4 Topics: Antineoplastic Agents; Benzamides; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome	2005
Use of 2-tracer PET to diagnose gastrointestinal stromal tumour and pheochromocytoma in patients with Carney triad and neurofibromatosis type 1. Scandinavian journal of gastroenterology, 2006, Volume: 41, Issue:5 Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Leiomyoma; Male; Mediastinal Neoplasms; Middle Aged; Neurofibromatosis 1; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals	2006
Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy. Scandinavian journal of gastroenterology, 2007, Volume: 42, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Biopsy, Fine-Needle; Diagnosis, Differential; Endosonography; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Gastroscopy; Humans; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon	2007
Early detection of response to imatinib therapy for gastrointestinal stromal tumor by using 18F-FDG-positron emission tomography and computed tomography imaging. World journal of gastroenterology, 2007, Apr-21, Volume: 13, Issue:15 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2007
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, May-01, Volume: 25, Issue:13 Topics: Antineoplastic Agents; Benzamides; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Multivariate Analysis; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Sensitivity and Specificity; Tomography, X-Ray Computed	2007
68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:8 Topics: Bombesin; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Stromal Tumors; Humans; Linear Models; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
[Is positron emission tomography (PET) scan useful for studying the extent of gastrointestinal stromal tumors]. Anales de medicina interna (Madrid, Spain : 1984), 2007, Volume: 24, Issue:6 Topics: Aged; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Neoplasm Proteins; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Remission Induction	2007
F-18 FDG PET/CT assessment of gastrointestinal stromal tumor response to sunitinib malate therapy. Clinical nuclear medicine, 2008, Volume: 33, Issue:3 Topics: Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Indoles; Liver Neoplasms; Middle Aged; Pyrroles; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sunitinib	2008
Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate. Clinical nuclear medicine, 2008, Volume: 33, Issue:3 Topics: Antineoplastic Agents; Benzamides; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals	2008